These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17884668)

  • 1. NICE judgment: good law risks bad science.
    Bird SM; Matthews F; Muniz G
    Lancet Neurol; 2007 Oct; 6(10):843-4. PubMed ID: 17884668
    [No Abstract]   [Full Text] [Related]  

  • 2. Raw deal for dementia patients in the UK.
    Lancet Neurol; 2007 Oct; 6(10):839. PubMed ID: 17884665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drugs for Alzheimer disease: what will the minister decide].
    Verhey FR; Scheltens P
    Tijdschr Gerontol Geriatr; 1998 Dec; 29(6):278-9. PubMed ID: 9894324
    [No Abstract]   [Full Text] [Related]  

  • 4. Appeal Court rules that NICE procedure was unfair.
    Dyer C
    BMJ; 2008 May; 336(7652):1035. PubMed ID: 18467392
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of mild Alzheimer's disease post-NICE.
    Connelly PJ; Passmore AP; Lawlor BA
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1262-3. PubMed ID: 17503543
    [No Abstract]   [Full Text] [Related]  

  • 6. NICE recommends drugs for moderate Alzheimer's disease.
    Mayor S
    BMJ; 2006 Jan; 332(7535):195. PubMed ID: 16439382
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing policy with dementia drugs: the UK NICE experience.
    Dening T
    Maturitas; 2009 Oct; 64(2):59-60. PubMed ID: 19767159
    [No Abstract]   [Full Text] [Related]  

  • 8. NICE to see the bigger picture.
    Lancet Neurol; 2006 Feb; 5(2):103. PubMed ID: 16426980
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients with mild Alzheimer's disease should have access to drugs, says draft NICE guidance.
    Kmietowicz Z
    BMJ; 2010 Oct; 341():c5562. PubMed ID: 20926475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for treatment].
    Olde Rikkert MG; Jansen RW
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2644; author reply 2645. PubMed ID: 10028367
    [No Abstract]   [Full Text] [Related]  

  • 11. Galantamine.
    Lowenthal MN
    Isr Med Assoc J; 2003 May; 5(5):388. PubMed ID: 12811964
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves galantamine for Alzheimer's disease.
    Thompson CA
    Am J Health Syst Pharm; 2001 Apr; 58(8):649. PubMed ID: 11329755
    [No Abstract]   [Full Text] [Related]  

  • 13. Harmonisation of availability of drugs for Alzheimer's disease.
    Winblad B
    Lancet; 1999 Jul; 354(9174):257. PubMed ID: 10421337
    [No Abstract]   [Full Text] [Related]  

  • 14. Third drug to treat Alzheimer's approved.
    Mayo Clin Health Lett; 2000 Aug; 18(8):4. PubMed ID: 10932951
    [No Abstract]   [Full Text] [Related]  

  • 15. New drug treatment for Alzheimer's disease: lessons for healthcare policy.
    Melzer D
    BMJ; 1998 Mar; 316(7133):762-4. PubMed ID: 9529416
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Jan; 277(1):10. PubMed ID: 8980195
    [No Abstract]   [Full Text] [Related]  

  • 17. NICE vindicated in UK's High Court.
    Horton R
    Lancet; 2007 Aug; 370(9587):547-8. PubMed ID: 17707735
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten years of cholinesterase inhibitors.
    Rodda J; Walker Z
    Int J Geriatr Psychiatry; 2009 May; 24(5):437-42. PubMed ID: 19367617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [British court supports limited use of drugs against dementia].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2418. PubMed ID: 17944011
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.